1. Home
  2. LLYVK vs JAZZ Comparison

LLYVK vs JAZZ Comparison

Compare LLYVK & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LLYVK
  • JAZZ
  • Stock Information
  • Founded
  • LLYVK 1991
  • JAZZ 2003
  • Country
  • LLYVK United States
  • JAZZ Ireland
  • Employees
  • LLYVK N/A
  • JAZZ N/A
  • Industry
  • LLYVK Broadcasting
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • LLYVK Industrials
  • JAZZ Health Care
  • Exchange
  • LLYVK Nasdaq
  • JAZZ Nasdaq
  • Market Cap
  • LLYVK 6.1B
  • JAZZ 7.3B
  • IPO Year
  • LLYVK N/A
  • JAZZ 2007
  • Fundamental
  • Price
  • LLYVK $72.16
  • JAZZ $121.43
  • Analyst Decision
  • LLYVK
  • JAZZ Buy
  • Analyst Count
  • LLYVK 0
  • JAZZ 14
  • Target Price
  • LLYVK N/A
  • JAZZ $173.93
  • AVG Volume (30 Days)
  • LLYVK 270.3K
  • JAZZ 567.6K
  • Earning Date
  • LLYVK 01-01-0001
  • JAZZ 02-26-2025
  • Dividend Yield
  • LLYVK N/A
  • JAZZ N/A
  • EPS Growth
  • LLYVK N/A
  • JAZZ 458.10
  • EPS
  • LLYVK N/A
  • JAZZ 7.04
  • Revenue
  • LLYVK N/A
  • JAZZ $3,992,712,000.00
  • Revenue This Year
  • LLYVK N/A
  • JAZZ $7.51
  • Revenue Next Year
  • LLYVK $10.14
  • JAZZ $6.84
  • P/E Ratio
  • LLYVK N/A
  • JAZZ $17.18
  • Revenue Growth
  • LLYVK N/A
  • JAZZ 5.23
  • 52 Week Low
  • LLYVK $33.50
  • JAZZ $99.06
  • 52 Week High
  • LLYVK $73.89
  • JAZZ $134.17
  • Technical
  • Relative Strength Index (RSI)
  • LLYVK 67.20
  • JAZZ 47.48
  • Support Level
  • LLYVK $65.57
  • JAZZ $118.72
  • Resistance Level
  • LLYVK $67.80
  • JAZZ $124.66
  • Average True Range (ATR)
  • LLYVK 1.44
  • JAZZ 2.79
  • MACD
  • LLYVK 0.31
  • JAZZ -0.24
  • Stochastic Oscillator
  • LLYVK 95.78
  • JAZZ 39.45

About LLYVK Liberty Media Corporation

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's strategy for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: